ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

ATEC Expands Platform with Launch of InVictus® OsseoScrew® Expandable Spinal Fixation

CARLSBAD, Calif.–(BUSINESS WIRE)– #ATEC–Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today the launch of the InVictus OsseoScrew Expandable Spinal Fixation System. InVictus OsseoScrew has been designed to be an alternative to the conventional use of cemented fenestrated screws… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Neurelis Announces Two Poster Presentations At The Annual Meeting Of The Child Neurology Society

SAN DIEGO: SAN DIEGO, Sept. 29, 2021 /PRNewswire/ — Neurelis, Inc. announced today that it is presenting two posters at the 50th Annual Meeting of the Child Neurology Society in Boston from September 29 through October 2. The first poster presents analyses from a Phase 3, long-term, open-label, repeat-dose safety… Click here to view original post… […]

No Picture
News

Kintara Therapeutics Announces Fiscal Year 2021 Financial Results and Provides Corporate Update

SAN DIEGO: SAN DIEGO, Sept. 29, 2021 /PRNewswire/ — https://www.kintara.com/ (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its fiscal year ended June 30, 2021 and provided a corporate update. CORPORATE HIGHLIGHTS AND RECENT… Click here to view original post… […]

No Picture
News

Thermo Fisher Scientific Opens Call for Grant Proposals to Fund Clinical Research in Hematology-oncology

CARLSBAD, Calif.: CARLSBAD, Calif., Sept. 29, 2021 /PRNewswire/ — To support clinical research needs using next-generation sequencing (NGS), Thermo Fisher Scientific today announced it is accepting new submissions for its Oncomine Clinical Research Grant. The latest call for proposals aims to provide funding for clinical research programs that leverage NGS… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

BioAtla Announces Private Placement of 2.7 Million Shares

SAN DIEGO: SAN DIEGO, Sept. 29, 2021 /PRNewswire/ — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, today announced that it has entered into stock purchase agreements with a group of institutional investors in connection with a private… Click here to view original post… […]

No Picture
News

Editas’ CRISPR-based eye therapy proves safe, but the jury’s still out on whether it works

Researchers at Editas Medicine revealed long-anticipated data for their CRISPR gene editing program Wednesday morning, the second-ever batch of human results for in vivo administration of the Nobel Prize-winning technology. And while the therapy appeared remarkably safe, a huge step forward in its own right, experts questioned whether the early… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

More Texas K-12 School Districts Turn to Award Winning Biodefense Air Filter to Protect Air Streams Against COVID-19 Variants and Future Airborne Threats

HOUSTON: TEXAS EDUCATION AGENCY DATA FROM SLIDELL AND GALVESTON ISDs SHOW IVP HELPS STOP INFECTION RATES AND KEEP SCHOOLS OPEN Conroe ISD, San Angelo ISD, Ricardo ISD, San Diego ISD, and Episcopal High School (Houston, TX) join Forth Worth ISD, Hogg ISD, Comal ISD, Banquette ISD, Houston ISD, Galveston ISD… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Uncategorized

Senior Associate Scientist, Neuroimmunology Assays – Johnson & Johnson Family of Companies – San Diego, CA

This is a technical position within the Janssen Biotherapeutics, New Platforms and Technologies, Blood Brain Barrier group. Complies to all lab safety rules.From Johnson & Johnson Family of Companies – Tue, 28 Sep 2021 02:07:14 […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Ensysce Biosciences Announces $15 Million Convertible Note Financing

SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug abuse and overdose, announced today that it has entered into a securities… Click here to view original post… […]

No Picture
News

Cidara Therapeutics to Present New Data for Rezafungin at IDWeek 2021

SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today announced that it will present new clinical and non-clinical data in three on-demand poster presentations, including data… Click here to view original post… […]

No Picture
News

Dr. Henry Ji, Sorrento Chairman and CEO, to Participate in the Virtual Cantor Global Healthcare Conference on September 29th, 2021

SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”), announced today that it will participate in the Cantor Virtual Healthcare Conference. Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Neurophth Announces the Completion of GMP Manufacturing Facility for Gene Therapy Products According to International Standards

WUHAN, China and SAN DIEGO: WUHAN, China and SAN DIEGO, Sept. 27, 2021 /PRNewswire/ — Neurophth Biotechnology Ltd., a fully-integrated genomic medicines company seeking to improve lives through the curative potential of gene therapies, announced the opening of its state-of-the-art manufacturing facility at the Phase II Suzhou Biomedical Industrial Park… Click here to view original post… […]

No Picture
News

Randomized trial demonstrates whole-genome sequencing leads to precision care for critically ill infants

SAN DIEGO: SAN DIEGO, Sept. 27, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) scientists, together with investigators from five children’s hospital across the US, have co-authored a study published today in JAMA Pediatrics reporting findings from the NICUSeq Randomized Time-Delayed Trial. Results show that use of clinical whole-genome sequencing (cWGS)… Click here to view original post… […]